SCHEMBL13339552

SCHEMBL13339552

CCOCCNC(=O)CCN1C(=O)CC(SF)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 3/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
EPHX2 P34913 1/20 0.33
CYP2C19 P33261 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
RECQL P46063 1/20 0.32
PCNA P12004 1/20 0.32
SLC9A3 P48764 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13311688 0.94 SMN1; SMN2 (0.35) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL13311682 0.93 SMN1; SMN2 (0.44) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL277686 0.90 SMN1; SMN2 (0.39) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL18264887 0.88 SMN1; SMN2 (0.37) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL13339558 0.86 POLB (0.33) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL18264611 0.85 HSD17B10 (0.37) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL277693 0.84 SMN1; SMN2 (0.36) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL23987003 0.84 HPGD (0.35) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL16172432 0.84 SMN1; SMN2 (0.39) SMN1; SMN2HPGDHTTHSD17B10POLB
SCHEMBL12410275 0.83 SMN1; SMN2 (0.41) SMN1; SMN2HPGDHTTHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130684-A1 POLYMER FACTOR IX MOIETY CONJUGATES NEKTAR THERAPEUTICS (US) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130684-A1 POLYMER FACTOR IX MOIETY CONJUGATES F9, F13A1, F8 SMN1; SMN2 2365/4885HPGD 1255/4885HTT 2131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.